PYC THERAPEUTICS LIMITED — Director's Dealing 2012

Apr 3, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	JOHN DOUGLAS WILSON
Date of last notice	31 JULY 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	GILLESPIE NOMINEES LTDDirector & Shareholder
Date of change	31 MARCH 2012
No. of securities held prior to change	INDIRECT250,000 ORDINARY SHARES618,337 UNLISTED OPTIONS AT $0.075EXPIRING 31/3/12
Class	UNLISTED OPTIONS
Number acquired	NIL
Number disposed	618,337
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	NIL
No. of securities held after change	INDIRECT250,000 ORDINARY SHARES
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	EXPIRED UNEXERCISED

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 314] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)Date of changeNo. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquiredInterest disposedValue/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuationInterest after change----- End of picture text -----

Part 3 –[+] Closed period

==> picture [434 x 98] intentionally omitted <==

----- Start of picture text ----- Were the interests in the securities or contracts detailed N/Aabove traded during a [+] closed period where prior writtenclearance was required?If so, was prior written clearance provided to allow the trade N/Ato proceed during this period?If prior written clearance was provided, on what date was this N/Aprovided?----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011